CCCC Competitors & Alternatives
Compare C4 Therapeutics Inc with similar stocks in the same industry
Biotechnology
CCCC
Main Stock$3.14
Tradestie Score
70
Market Cap
$153.02M
Revenue Growth
0.0%
Analyst Upside
+324.6%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$7.50
|
$454.29M | - | 44 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 50 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$11.47
|
$448.32M | - | 51 | Compare |
|
AUTL
Autolus Therapeutics plc American Depositary Share
|
$1.85
|
$444.46M | - | 63 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$7.21
|
$422.50M | - | 55 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$13.84
|
$407.71M | - | 56 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$12.24
|
$386.68M | - | 69 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.04
|
$382.04M | - | 58 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.51
|
$371.64M | - | 47 | Compare |
More CCCC Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry